Search by keyword or author

Experiences and Management Practices of Individuals Living with Sickle Cell Anemia in Nigeria

Published: August 14, 2026 | Views: 41

Authors

Abidemi Esther Ojo, Regina Oghenevwede Golagha, Olugbenga Anthony Ojo, Adejare Rasaq Oloyede, Oluwabusola Oluwayemi Adegbesan, and Eniola Akindele

Keywords
Sickle cell anemia, HbSS genotype, Stigma, Frequent clinical complications

Abstract

Background: Sickle cell anemia (SCA) remains a major public health concern in Nigeria, where it significantly affects the physical, emotional, and social well-being of affected individuals. Despite advancements in medical care, many patients continue to face challenges related to disease management and societal perceptions.

Purpose: This study aimed to explore the experiences and management practices of individuals living with SCA in Nigeria.

Methods: A descriptive cross-sectional study was conducted among individuals living with sickle cell anemia in Nigeria using a structured online questionnaire distributed through WhatsApp support groups. Ethical approval was obtained from the Federal Medical Centre, Abeokuta, Nigeria. A voluntary participant recruitment approach was employed, and data collected included socio-demographic characteristics, disease experiences, pain triggers, and management practices. Data were analyzed using descriptive statistics in SPSS and Microsoft Excel.

Result: Out of 307 individuals contacted, 66 respondents completed the survey (21.5% response rate). Most respondents were female (69.6%), aged 31-40 years (51.5%), and had the HbSS genotype (72.7%). Frequent pain crises were reported by 42.4% of participants, while 69.7% stated that sickle cell disease had negatively affected their life pursuits. Societal discrimination was experienced by 68.1% of respondents. Malaria was the most commonly reported trigger of pain crises (34%), followed by stress and extremely cold weather. Medication was the most common management strategy (47.0%), while hospital visitation was the preferred approach during crises (59%).

Conclusion: The study highlights the complex realities of living with SCA in Nigeria, characterized by frequent clinical complications, diverse management practices, and substantial psychosocial burdens.

References

  • Adegoke, S., & Abioye-Kuteyi, E. (2012). Psychosocial burden of sickle cell disease on the family, Nigeria. African Journal of Primary Health Care and Family, 4(1), 1–6. https://doi.org/10.4102/phcfm.v4i1.380
  • Adeloye, D., Auta, A., Ale, B. M., Thompson, J. Y., Rudan, I., & Global Health Epidemiology Research Group (GHERG). (2026). Prevalence estimates of sickle cell disease among children and adolescents in sub-Saharan Africa: A systematic review and modelling analysis. The Lancet. Child and Adolescent Health, 10(6), 438–447. https://doi.org/10.1016/S2352-4642(26)00048-9
  • Adewoyin, A. S. (2015). Management of sickle cell disease: A review for physician education in Nigeria (Sub-Saharan Africa). Anemia, 2015(1), 791498. https://doi.org/10.1155/2015/791498
  • Adigwe, O. P., Onavbavba, G., & Onoja, S. O. (2023). Impact of sickle cell disease on affected individuals in Nigeria: A critical review. International Journal of General Medicine, 16, 3503–3515. https://doi.org/10.2147/IJGM.S410015
  • Akodu, S., Diaku-Akinwumi, I., & Njokanma, O. (2013). Age at diagnosis of sickle cell anemia in Lagos, Nigeria. Mediterranean Journal of Hematology and Infectious Diseases, 5(1), e2013001. https://doi.org/10.4084/mjhid.2013.001
  • Ambe, J. P., Mava, Y., & Chirdan, O. (2001). Clinical profile of sickle cell anemia in Nigerian children and effects on schooling. African Journal of Medicine and Medical Sciences, 30(3), 195–199. https://pubmed.ncbi.nlm.nih.gov/23208475/
  • Ameh, S. J., Tarfa, F. D., & Ebeshi, B. U. (2012). Traditional herbal management of sickle cell anemia: Lessons from Nigeria. Anemia, 2012(1), 607436. https://doi.org/10.1155/2012/607436
  • Anie, K. A. (2005). Psychological complications in sickle cell disease. British Journal of Haematology, 129(6), 723–729. https://doi.org/10.1111/j.1365-2141.2005.05500.x
  • Anie, K. A., & Green, J. (2015). Psychological therapies for sickle cell disease and pain. The Cochrane Database of Systematic Reviews, 2015(5), CD001916. https://doi.org/10.1002/14651858.CD001916.pub3
  • Ballas, S. K., Lieff, S., Benjamin, L. J., Dampier, C. D., Heeney, M. M., Hoppe, C., Johnson, C. S., Rogers, Z. R., Smith-Whitley, K., Wang, W. C., Telen, M. J., & Investigators, Comprehensive Sickle Cell Centers. (2010). Definitions of the phenotypic manifestations of sickle cell disease. American Journal of Hematology, 85(1), 6–13. https://doi.org/10.1002/ajh.21550
  • Berhe, K. T., Gesesew, H. A., & Ward, P. R. (2024). Traditional healing practices, factors influencing to access the practices and its complementary effect on mental health in sub-Saharan Africa: A systematic review. BMJ Open, 14(9), e083004. https://doi.org/10.1136/bmjopen-2023-083004
  • Brown, B. J., Okereke, J. O., Lagunju, I. A., Orimadegun, A. E., Ohaeri, J. U., & Akinyinka, O. O. (2010). Burden of health-care of carers of children with sickle cell disease in Nigeria. Health & Social Care in the Community, 18(3), 289–295. https://doi.org/10.1111/j.1365-2524.2009.00903.x
  • Bulgin, D., Tanabe, P., & Jenerette, C. (2018). Stigma of sickle cell disease: A systematic review. Issues in Mental Health Nursing, 39(8), 675–686. https://doi.org/10.1080/01612840.2018.1443530
  • Bunn, H. F. (1997). Pathogenesis and treatment of sickle cell disease. The New England Journal of Medicine, 337(11), 762–769. https://doi.org/10.1056/NEJM199709113371107
  • Canals-Gispert, L., Cañas-Martínez, A., Huesa, G., Suárez-Calvet Alomà, M., Milà-Alomà, M., Arenaza-Urquijo, E., Cirillo, D., Dimech, A. S., Iulita, M. F., Martinkova, J. N., Tartaglia, M. C., Quevenco, F. C., Chadha, A. S., Sánchez-Benavides, G., Minguillón, C., Ferretti, M. T., Fauria, K., Brugulat-Serrat, A., & ALFA Study. (2024). Impact of gender on the willingness to participate in clinical trials and undergo related procedures in individuals from an Alzheimer’s prevention research cohort. Alzheimer’s Research & Therapy, 16(1), 263. https://doi.org/10.1186/s13195-024-01626-1
  • Diaku-Akinwumi, I. N., Abubakar, S. B., Adegoke, S. A., Adeleke, S., Adewoye, O., Adeyemo, T., Akinbami, A., Akinola, N. O., Akinsulie, A., Akinyoola, A., Aneke, J., Awwalu, S., Babadoko, A., Brown, B., Ejike, O., Emodi, I., George, I., Girei, A., Hassan, A., Kangiwa, G. U., Lawal, O. A., Mabogunje, C., Madu, A. J., Mustapha, A., Ndakotsu, M., Nnodu, O. E., Nwaneri, D., Odey, F. F., Ohiaeri, C., Olaosebikan, R., Olatunya, O. S., Oniyangi, O., Opara, H., Ugwu, N. I., Musa, A. U., Abdullahi, S., Usman, A., Utuk, E., Jibir, B. W., & Adekile, A. D. (2016). Blood transfusion services for patients with sickle cell disease in Nigeria. International Health, 8(5), 330–335. https://doi.org/10.1093/inthealth/ihw014
  • Elendu, C., Amaechi, D. C., Alakwe-Ojimba, C. E., Elendu, T. C., Elendu, R. C., Ayabazu, C. P., Aina, T. O., Aborisade, O., & Adenikinju, J. S. (2023). Understanding sickle cell disease: Causes, symptoms, and treatment options. Medicine, 102(38), e35237. https://doi.org/10.1097/MD.0000000000035237
  • Essien, E. A., Winter-Eteng, B. F., Onukogu, C. U., Nkangha, D. D., & Daniel, F. M. (2023). Psychosocial challenges of persons with sickle cell anemia: A narrative review. Medicine, 102(47), e36147. https://doi.org/10.1097/MD.0000000000036147
  • Gazta, P., Gautam, J., Thakor, M., Bhardwaj, P., & Mohanty, S. S. (2026). Role of the primary healthcare providers in sickle cell disease management: A scoping review. Journal of Community Genetics, 17(2), 35. https://doi.org/10.1007/s12687-026-00867-x
  • Hassell, K. L. (2010). Population estimates of sickle cell disease in the U.S. American Journal of Preventive Medicine, 38(4), S512–S521. https://doi.org/10.1016/j.amepre.2009.12.022
  • Juburi, G. A., Okoye, O., Majeed, A., Knight, Y., Green, S. A., Banarsee, R., … & Phekoo, K. J. (2012). Views of patients about sickle cell disease management in primary care: A questionnaire-based pilot study. JRSM Short Reports, 3(11), 1–5. https://doi.org/10.1258/shorts.2012.011173
  • Kilonzi, M., Mwakawanga, D. L., Felician, F. F., Mlyuka, H. J., Chirande, L., Myemba, D. T., Sambayi, G., Mutagonda, R. F., Mikomangwa, W. P., Ndunguru, J., Jonathan, A., Ruggajo, P., Minja, I. K., Balandya, E., Makani, J., & Sirili, N. (2022). The effects of sickle cell disease on the quality of life: A focus on the untold experiences of parents in Tanzania. International Journal of Environmental Research and Public Health, 19(11), 6871. https://doi.org/10.3390/ijerph19116871
  • Mangla, A., Agarwal, N., & Maruvada, S. (2023). Sickle cell anemia. In StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482164/
  • McGann, P. T., Nero, A. C., & Ware, R. E. (2013). Current management of sickle cell anemia. Cold Spring Harbor Perspectives in Medicine, 3(8), a011817. https://doi.org/10.1101/cshperspect.a011817
  • Meraya, A. M., Banji, O. J. F., Menachery, S. J., Malhan, H. M. A., Halawi, H. A. A., Moraya, D., Hakami, H. A., Kubayni, A. M., Alfaifi, Y. Y., Ghareeb, H. I., Rasayn, M. A. A., & Alfaifi, R. A. (2026). Clinical, humanistic, and economic burden of sickle cell disease in The Jazan Region, Saudi Arabia. PLOS ONE, 21(5), e0348759. https://doi.org/10.1371/journal.pone.0348759
  • Mutombo, P. N., Kasilo, O. M. J., James, P. B., Wardle, J., Kunle, O., Katerere, D., Wambebe, C., Matsabisa, M. G., Rahmatullah, M., Mukankubito, I., Sheridan, R., Sanogo, R., Nissapatorn, V., Sivakorn, C., Tripathy, S., Goyal, R., & Dhobi, M. (2023). Experiences and challenges of African traditional medicine: Lessons from COVID-19 pandemic. BMJ Global Health, 8(8), e010813. https://doi.org/10.1136/bmjgh-2022-010813
  • Nelson, M., Noisette, L., Pugh, N., Gordeuk, V., Hsu, L. L., Wun, T., Shah, N., Glassberg, J., Kutlar, A., Hankins, J. S., King, A. A., Brambilla, D., & Kanter, J. (2024). The clinical spectrum of HbSC sickle cell disease not a benign condition. British Journal of Haematology, 205(2), 653–663. https://doi.org/10.1111/bjh.19523
  • Ohene-Frempong, K., Weiner, S. J., Sleeper, L. A., Miller, S. T., Embury, S., Moohr, J. W., Wethers, D. L., Pegelow, C. H., & Gill, F. M. (1998). Cerebrovascular accidents in sickle cell disease: Rates and risk factors. Blood, 91(1), 288–294. https:// https://pubmed.ncbi.nlm.nih.gov/9414296/
  • Olatunya, O. S., Babatola, A. O., Adeniyi, A. T., Lawal, O. A., Daramola, A. O., Agbesanwa, T. A., Olumuyiwa Ojo, T., Ajayi, P. O., Ibijola, A. A., Komolafe, A. K., & Adekile, A. (2021). Determinants of care-seeking practices for children with sickle cell disease in Ekiti, Southwest Nigeria. Journal of Blood Medicine, 12, 123–132. https://doi.org/10.2147/JBM.S294952
  • Serjeant, G. R. (2013). The natural history of sickle cell disease. Cold Spring Harbor Perspectives in Medicine, 3(10), a011783. https://doi.org/10.1101/cshperspect.a011783
  • Shapiro, B. S., Dinges, D. F., Orne, E. C., Bauer, N., Reilly, L. B., Whitehouse, W. G., Ohene-Frempong, K., & Orne, M. T. (1995). Home management of sickle cell-related pain in children and adolescents: Natural history and impact on school attendance. Pain, 61(1), 139–144. https://doi.org/10.1016/0304-3959(94)00164-A
  • Tewari, S., Brousse, V., Piel, F., & Menzel, S. (2015). Environmental determinants of severity in sickle cell disease. Haematologica, 100(9), 1108–1116. https://doi.org/10.3324/haematol.2014.120030
  • Thomas, V. J., & Taylor, L. M. (2002). The psychosocial experience of people with sickle cell disease and its impact on quality of life: Qualitative findings from focus groups. British Journal of Health Psychology, 7(3), 345–363. https://doi.org/10.1348/135910702760213724
  • Verdugo-Castro, S., Sánchez-Gómez, M. C., & García-Holgado, A. (2023). Factors associated with the gender gap in the STEM sector: Comparison of theoretical and empirical concept maps and qualitative SWOT analysis. Heliyon, 9(6), e17499. https://doi.org/10.1016/j.heliyon.2023.e17499
  • Yusuf, H. R., Atrash, H. K., Grosse, S. D., Parker, C. S., & Grant, A. M. (2010). Emergency department visits made by patients with sickle cell disease: A descriptive study, 1999–2007. American Journal of Preventive Medicine, 38(4 Suppl), S536–S541. https://doi.org/10.1016/j.amepre.2010.01.001

How to Cite

Abidemi Esther Ojo, Regina Oghenevwede Golagha, Olugbenga Anthony Ojo, Adejare Rasaq Oloyede, Oluwabusola Oluwayemi Adegbesan, and Eniola Akindele. Experiences and Management Practices of Individuals Living with Sickle Cell Anemia in Nigeria. J. Multidiscip. Res. Healthcare. 2026, 12, 57-66
Experiences and Management Practices of Individuals Living with Sickle Cell Anemia in Nigeria

Current Issue

PeriodicityBiannually
Issue-1June
Issue-2December
ISSN Print2393-8536
ISSN Online2393-8544
RNI No.CHAENG/2014/57978

This work is licensed under a Creative Commons Attribution 4.0 International License.

Articles in Journal of Multidisciplinary Research in Healthcare by Chitkara University Publications are Open Access articles that are published with licensed under a Creative Commons Attribution- CC-BY 4.0 International License. Based on a work at https://jmrh.chitkara.edu.in/. This license permits one to use, remix, tweak and reproduction in any medium, even commercially provided one give credit for the original creation.

View Legal Code of the above-mentioned license, https://creativecommons.org/licenses/by/4.0/legalcode

View Licence Deed here https://creativecommons.org/licenses/by/4.0/

Creative Commons License

Journal of Multidisciplinary Research in Healthcare by Chitkara University Publications is licensed under a Creative Commons Attribution 4.0 International License.
Based on a work at https://jmrh.chitkara.edu.in/

Visibility, Memberships and Ethics